Negative symptoms as key features of depression among cannabis users: a preliminary report.

OBJECTIVE: Cannabis use is frequent among depressed patients and may lead to the so-called "amotivational syndrome", which combines symptoms of affective flattening and loss of emotional reactivity (i.e. the so-called "negative" symptomatology). The aim of this study was to investigate the negative symptomatology in depressed patients with concomitant cannabis use disorders (CUDs) in comparison with depressed patients without CUDs. PATIENTS AND METHODS: Fifty-one patients with a diagnosis of Major Depressive Disorder (MDD) and concomitant CUD and fifty-one MDD patients were enrolled in the study. The 21-Item Hamilton Depression Rating Scale (HDRS) and the negative symptoms subscales of the Positive and Negative Syndrome Scale (PANSS) were used to assess depressive and negative symptomatology. RESULTS: Patients with cannabis use disorders presented significantly more severe negative symptoms in comparison with patients without cannabis use (15.18 ± 2.25 vs 13.75 ± 2.44; t100 = 3.25 p = 0.002). DISCUSSION: A deeper knowledge of the "negative" psychopathological profile of MDD patients who use cannabis may lead to novel etiopathogenetic models of MDD and to more appropriate treatment approaches

VOC Air Pollution in Urban Areas – A Microscale Model experimentally validated

Previous theoretical and experimental studies (S. T. A.- Università di Pisa (DIMNP), 1998; Agostini E., M. Corezzi, I. Ciucci, M. Mazzini 2003; Agostini E., I. Ciucci, M. Mazzini, S. Strinati, 2003) even if partial, evidenced the problem of atmospheric pollution by Volatile Organic Compounds (VOC) in Livorno (Tuscany). This pollution is caused mainly by the presence of an important refinery, other industries and traffic. Other relevant VOC emission sources are linked to port activities and to numerous small companies using paints and solvents. Figure 1 shows the map of Livorno, situated on the Tyrrhenian sea. This is a simple site from the orography point of view, except for the southern zone where a promontory and a chain of hills impose a more complex pattern of air fluxes. The industrial zone is localized in the north of the map and the harbour activities along the coast (west area). It’s difficult to define a specific zone for the companies using solvents and paints, even though a grater concentration is present around the axis Viale Carducci – Piazza Repubblica – Via Grande. The map outlines also the air pollution measurement stations managed by ARPAT (points) and the meteorological stations (crosses). The simulation of the emission scenario, was done by using ISC3 (U. S. Environmental Protection Agency) code for treating diffuse sources and CALINE4 (California Department of Transportation) for those related to traffic on main roads. The research work focuses the attention on the results of model validation by experimental data obtained along the roads of the studied area. The possibility to extend the application of this model to sites with similar orography and town-planning characteristics is also discussed in the aim of obtaining information about the level of atmospheric pollution on sites where there aren’t measurement stations

5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer

We have reported that an alternating regimen of bolus and continuous infusion 5-fluorouracil (FU) was superior to bolus FU in terms of response rate and progression-free survival in advanced colorectal cancer. Biochemical modulation was an essential part of this regimen and it was selective for the schedule of FU administration: bolus FU was in fact modulated by methotrexate (MTX) while continuous infusion FU was potentiated by 6-s-leucovorin (LV). Considering the low cost and the favourable report on the activity of mitomycin C (mito) added to CI FU, we have incorporated this agent in the infusional part of our treatment programme. 105 patients with untreated, advanced, measurable colorectal cancer were accrued from 13 Italian centres and treated with the following regimen. 2 biweekly cycles of FU bolus (600 mg/m2), modulated by MTX (24 h earlier, 200 mg/m2) were alternated with a 3-week continuous infusion of FU (200 mg/m2daily), modulated by LV (20 mg/m2weekly bolus). Mito, 7 mg/m2, was given on the first day of the infusional period. After a 1 week rest, the whole cycle (8 weeks) was repeated, if indicated. 5 complete and 34 partial responses were obtained (response rate, 37% on the intention to treat basis; 95% confidence limits, 28–46%). After a median follow-up time of 26 months, 37 patients are still alive. The median progression-free survival is 7.7 months with an overall survival of 18.8 months and a 2-year survival rate of 30%. The regimen was very well tolerated with fewer than 13% of patients experiencing WHO grade III–IV toxicity. These results are consistent with those obtained by our group in 3 previous trials of schedule specific biochemical modulation of FU. They also indicate a highly active, little toxic, inexpensive regimen of old drugs to be used (a) as an alternative to the more expensive combinations including CPT-11 or oxaliplatin or (b) as the basis for combination programmes with these agents. © 2001 Cancer Research Campaign http://www.bjcancer.co